The stock is in a pronounced recovery phase from a deep trough, having posted a significant 34.07% gain over the past year. However, the current price of $65.60 sits at approximately 78.7% of its 52-week range ($34.13 to $83.35), indicating it has recovered substantially from its lows but remains meaningfully below its recent peak, suggesting the rally may be maturing and facing resistance. Recent momentum has turned negative, with the stock declining 8.11% over the past month, which starkly contrasts with its strong 1-year performance and signals a potential short-term consolidation or pullback. This divergence is further highlighted by the stock's 3-month gain of only 0.88%, significantly underperforming the S&P 500's 4.0% decline over the same period, indicating relative strength is waning after a sharp run-up earlier in the year. Key technical support is anchored at the 52-week low of $34.13, though a more relevant near-term floor may be found around the $60-$62 level where the stock recently found footing. Immediate resistance is at the 52-week high of $83.35, a level that represents substantial upside but also a formidable barrier given the recent retreat from the $80 area. A sustained breakout above $83.35 would signal a resumption of the primary bull trend, while a breakdown below the $60 support could indicate a deeper correction is underway. The stock's beta of 1.474 confirms it is approximately 47% more volatile than the broader market, which amplifies both upside and downside moves and is a critical factor for risk-aware investors.

Revenue has demonstrated a clear recovery trajectory, with the most recent quarterly revenue reaching $1.186 billion, representing a 15.59% year-over-year increase. This growth marks a significant turnaround from the prior quarters of decline, as revenue sequentially improved from $970.5 million in Q4 2025 to $1.186 billion in Q3 2026. The semiconductor products segment, constituting $1.127 billion of the total, is the primary growth driver, indicating core demand is rebounding. This accelerating growth trend is a positive signal that the company is emerging from the cyclical downturn that impacted its financials in early 2025. Profitability has returned but remains under pressure. The company reported net income of $34.9 million for Q3 2026, a sharp improvement from a net loss of $154.6 million in Q4 2025. Gross margin expanded significantly to 59.6% in the latest quarter, up from 51.6% in Q4 2025 and 41.2% in Q2 2026, reflecting better pricing and product mix. However, operating margin stands at 12.79%, which, while positive, indicates that operating expenses remain elevated relative to the revenue base, leaving room for further efficiency gains as the recovery solidifies. The balance sheet shows moderate leverage with a debt-to-equity ratio of 0.80, which is manageable for the industry. Financial health is supported by robust free cash flow generation, with TTM free cash flow of $819.9 million. The current ratio of 2.59 indicates strong short-term liquidity. Return on equity (ROE) is currently negligible at -0.00007, and return on assets (ROA) is a low 1.16%, reflecting the recent period of depressed earnings, but the positive net income and cash flow suggest these metrics are poised for improvement as profitability normalizes.